<DOC>
	<DOCNO>NCT01291602</DOCNO>
	<brief_summary>This single multiple dose study healthy male female ( non-childbearing potential ) Japanese volunteer , assess safety , tolerability , blood urine drug level intravenous ( IV ) NXL104 alone give combination ceftazidime .</brief_summary>
	<brief_title>A Study Assess Safety , Tolerability Pharmacokinetics NXL104 Alone Combination With Ceftazidime Administered Single Repeated Intravenous Doses Healthy Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Avibactam</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<criteria>To consider 'Japanese ' , volunteer 's parent , grandparent must Japanese . The volunteer must bear Japan , valid Japanese passport must live outside Japan 5 year Have body mass index ( BMI ) 17 27 kg/m2 inclusive weigh least 45 kg 100 kg . Females must lactate , must nonchildbearing potential ( postmenopausal least 12 month document irreversible surgical sterilization hysterectomy , bilateral oophorectomy , bilateral salpingectomy tubal ligation History presence gastrointestinal , liver kidney disease , condition know interfere absorption , distribution , metabolism , excretion drug Symptoms clinically significant illness 3 month study History hypersensitivity ( eg , anaphylaxis ) , serious allergy , serious reaction carbapenem , cephalosporin , Î²lactam antibiotic Use within 14 day prior first study dose overthecounter ( include St. John 's Wort herbal product ) prescription medication Smoker 5 cigarettes/day equivalent use nicotine product previous 3 month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>NXL104</keyword>
	<keyword>ceftazidime</keyword>
	<keyword>CAZ104</keyword>
	<keyword>Healthy Japanese volunteer</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Single Multiple Dose Study</keyword>
</DOC>